Microbial tryptophan metabolites are well-known activators of AhR, particularly in the gut [15,18], where AhR activation enhances the intestinal barrier function and stimulates GLP-1 secretion, leading to improved glucose metabolism and hepatic steatosis [31]. The gene discussed is AHR; the disease is fatty liver disease.